Belite Bio (BLTE) News Today

Belite Bio (NASDAQ:BLTE) Sets New 12-Month High at $50.40

Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totalling 222,500 shares, a growth of 516.3% from the June 15th total of 36,100 shares. Based on an average trading volume of 53,500 shares, the days-to-cover ratio is presently 4.2 days.

Belite Bio (NASDAQ:BLTE) Trading 6.2% Higher

Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the target of a large drop in short interest in June. As of June 15th, there was short interest totalling 36,100 shares, a drop of 22.9% from the May 31st total of 46,800 shares. Based on an average trading volume of 51,900 shares, the short-interest ratio is currently 0.7 days.

Belite Bio (NASDAQ:BLTE) Sees Strong Trading Volume

Shares of Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) have been given a consensus recommendation of "Buy" by the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1-year targe

Cantor Fitzgerald restated an "overweight" rating on shares of Belite Bio in a research note on Thursday.

Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 46,800 shares, an increase of 32.2% from the May 15th total of 35,400 shares. Based on an average daily trading volume, of 43,500 shares, the days-to-cover ratio is currently 1.1 days.

HC Wainwright reissued a "buy" rating and set a $59.00 price target on shares of Belite Bio in a research report on Thursday.

Belite Bio (NASDAQ:BLTE) Reaches New 52-Week High at $49.25

Armistice Capital LLC bought a new stake in Belite Bio, Inc (NASDAQ:BLTE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 36,000 shares of the company's stock, valued at approximately

Belite Bio (NASDAQ:BLTE) Shares Down 2.8%

Belite Bio (NASDAQ:BLTE) Hits New 12-Month High at $49.16

Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) saw a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 35,400 shares, a growth of 87.3% from the April 30th total of 18,900 shares. Based on an average daily trading volume, of 40,100 shares, the days-to-cover ratio is presently 0.9 days.

Belite Bio, Inc (NASDAQ:BLTE - Free Report) - Investment analysts at Cantor Fitzgerald dropped their FY2024 EPS estimates for Belite Bio in a research note issued to investors on Wednesday, May 15th. Cantor Fitzgerald analyst J. Kim now expects that the company will post earnings of ($1.04) per s

Benchmark reissued a "buy" rating and set a $57.00 target price on shares of Belite Bio in a research report on Thursday.

HC Wainwright reaffirmed a "buy" rating and set a $59.00 price target on shares of Belite Bio in a research note on Wednesday.

Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 18,900 shares, a drop of 44.4% from the April 15th total of 34,000 shares. Based on an average daily volume of 40,600 shares, the days-to-cover ratio is presently 0.5 days.

Belite Bio (NASDAQ:BLTE) will be releasing earnings after the market closes on Tuesday, May 14, Zacks reports.

Belite Bio (NASDAQ:BLTE) Shares Gap Down to $43.20

Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 34,000 shares, a decrease of 13.0% from the March 31st total of 39,100 shares. Based on an average trading volume of 52,300 shares, the short-interest ratio is presently 0.7 days.

Belite Bio (NASDAQ:BLTE) Shares Up 6.7%

Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the recipient of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 39,100 shares, a decline of 34.3% from the March 15th total of 59,500 shares. Based on an average daily volume of 61,400 shares, the days-to-cover ratio is currently 0.6 days.

Belite Bio (NASDAQ:BLTE) Shares Gap Down to $39.98

Belite Bio (NASDAQ:BLTE) Shares Down 1.8%

Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 59,500 shares, a growth of 20.7% from the February 29th total of 49,300 shares. Based on an average daily volume of 74,100 shares, the days-to-cover ratio is presently 0.8 days.

Belite Bio (NASDAQ:BLTE) Trading Down 4.8%